JohnPodtetenieff Ph.D.

Associate

Munich + 49.89.20.60.42.200

John Podtetenieff handles patent prosecution and contentious matters on behalf of biotechnology, pharmaceutical, and chemistry sector clients.

John has experience in the full spectrum of patent proceedings before the European Patent Office — including drafting, prosecution, opposition, and appeal — as well as national infringement and invalidity proceedings. He has assisted diverse clients ranging from small start-ups in need of basic IP advice to multinational pharmaceutical companies requiring advice on their freedom-to-operate and litigation matters.

Prior to practicing intellectual property law, John was a research scientist working in the fields of metagenomic drug discovery, biocatalysis, directed evolution, and protein engineering, with particular emphasis on developing efficient green catalysts yielding enantiomerically pure molecules. He is a member of the Chartered Institute of Patent Attorneys and the European Patent Institute.

Experience

  • ToolGen seeks patent protection for CRISPR technologyJones Day is prosecuting patent applications and developing a patent portfolio on behalf of ToolGen, Inc. for CRISPR technology.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.